| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The state of Bolivar in Venezuela experiences episodic outbreaks of multidrug-resistant Plasmodium falciparum malaria. We obtained P. falciparum-infected blood samples in Bolivar in 1998-2000, and performed molecular assays for mutations conferring resistance to the antifolate combination of sulfadoxine-pyrimethamine (SP) and to chloroquine. All infections carried the dihydrofolate reductase (dhfr) S108A and N51I mutations, and 45% of the infections had the dhfr C50R mutation, which has been implicated in mid-level resistance to SP. Two dihydropteroate synthase (dhps) mutations also involved in SP resistance, A581G and K540E, were detected in 90% and 67% of the samples, respectively. The dhfr 1164L mutation, which confers high-level resistance, was not identified. The P. falciparum chloroquine resistance transporter (pfcrt) K76T mutation, which is critical for chloroquine resistance, was found in 167 of 168 infections. Six dhfr/dhps allelotypes and four pfcrt-resistant alleles were observed. Their interrelationships suggest a semi-clonal propagation of P. falciparum malaria in Bolivar, and an invasion of multi-resistant pathogens from Brazil. Despite national restrictions on the use of SP and chloroquine, genotypic resistance to these therapies remains widespread in Bolivar.
This article has been cited by other articles:
|
|
 |
|
  W. D. Fairlie, T. P. Spurck, J. E. McCoubrie, P. R. Gilson, S. K. Miller, G. I. McFadden, R. Malby, B. S. Crabb, and A. N. Hodder Inhibition of Malaria Parasite Development by a Cyclic Peptide That Targets the Vital Parasite Protein SERA5 Infect. Immun., September 1, 2008; 76(9): 4332 - 4344. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Japrung, U. Leartsakulpanich, S. Chusacultanachai, and Y. Yuthavong Conflicting Requirements of Plasmodium falciparum Dihydrofolate Reductase Mutations Conferring Resistance to Pyrimethamine-WR99210 Combination Antimicrob. Agents Chemother., December 1, 2007; 51(12): 4356 - 4360. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. McCollum, K. Mueller, L. Villegas, V. Udhayakumar, and A. A. Escalante Common Origin and Fixation of Plasmodium falciparum dhfr and dhps Mutations Associated with Sulfadoxine-Pyrimethamine Resistance in a Low-Transmission Area in South America Antimicrob. Agents Chemother., June 1, 2007; 51(6): 2085 - 2091. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. K. Laufer, P. C. Thesing, N. D. Eddington, R. Masonga, F. K. Dzinjalamala, S. L. Takala, T. E. Taylor, and C. V. Plowe Return of Chloroquine Antimalarial Efficacy in Malawi N. Engl. J. Med., November 9, 2006; 355(19): 1959 - 1966. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Zhou, A. C. Poe, J. Limor, K. K. Grady, I. Goldman, A. M. McCollum, A. A. Escalante, J. W. Barnwell, and V. Udhayakumar Pyrosequencing, a High-Throughput Method for Detecting Single Nucleotide Polymorphisms in the Dihydrofolate Reductase and Dihydropteroate Synthetase Genes of Plasmodium falciparum J. Clin. Microbiol., November 1, 2006; 44(11): 3900 - 3910. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Ahmed, D. Bararia, S. Vinayak, M. Yameen, S. Biswas, V. Dev, A. Kumar, M. A. Ansari, and Y. D. Sharma Plasmodium falciparum Isolates in India Exhibit a Progressive Increase in Mutations Associated with Sulfadoxine-Pyrimethamine Resistance Antimicrob. Agents Chemother., March 1, 2004; 48(3): 879 - 889. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
